Comparison of Contrast Agents in Liver MR for the Detection of Hepatic Metastases

PHASE4TerminatedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 22, 2021

Primary Completion Date

May 6, 2025

Study Completion Date

May 8, 2025

Conditions
Oligometastatic DiseaseLiver MetastasesColorectal Cancer
Interventions
DRUG

Gadoxetate disodium

Gadoxetate disodium is now mainly used for the purpose of HBP liver MR imaging to save MR scanner time and total examination time.

DRUG

Gadobenate dimeglumine

The most commonly used MR contrast agent in abdominal imaging is gadobenate dimeglumine, which has mainly the characteristics of an extracellular agent used for most indications of MR examinations.

Trial Locations (1)

80045

University of Colorado Hospital, Aurora

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Bracco Diagnostics, Inc

INDUSTRY

collaborator

National Cancer Institute (NCI)

NIH

lead

University of Colorado, Denver

OTHER